These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 1901200

  • 1. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK.
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [Abstract] [Full Text] [Related]

  • 5. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy.
    Hong Kong Chest Service/British Medical Research CouncilMedical Research Council Cardiothoracic Epidemiology Group, Brompton Hospital, London..
    Am Rev Respir Dis; 1989 Dec; 140(6):1618-22. PubMed ID: 2604291
    [Abstract] [Full Text] [Related]

  • 9. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
    [Abstract] [Full Text] [Related]

  • 10. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ, Perng RP.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [Abstract] [Full Text] [Related]

  • 11. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov 09; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract] [Full Text] [Related]

  • 12. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.
    Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281
    [Abstract] [Full Text] [Related]

  • 13. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec 11; 136(6):1339-42. PubMed ID: 2891333
    [Abstract] [Full Text] [Related]

  • 14. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug 11; 118(2):219-28. PubMed ID: 100029
    [Abstract] [Full Text] [Related]

  • 15. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb 11; 123(2):165-70. PubMed ID: 7015933
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
    Wolde K, Lema E, Roscigno G, Abdi A.
    Ethiop Med J; 1992 Apr 11; 30(2):63-8. PubMed ID: 1345030
    [Abstract] [Full Text] [Related]

  • 18. [A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].
    Agounitestane D, Chiheb M, Khaled S, Ait Khaled N, Boulahbal F, Chaulet P.
    Rev Mal Respir; 1990 Apr 11; 7(3):209-13. PubMed ID: 2114029
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun 11; 56(2):81-96. PubMed ID: 1103400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.